SuperworthMira Pharmaceuticals shares outstanding MIRA
Diluted shares outstanding, averaged over each quarter, from 2022.
- Latest quarter, to Jun 30, 2026
- 42M
- On a year earlier
- +147.4%
- more shares
Mira Pharmaceuticals had 42M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 147.4% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 40.6M | +146% |
| FY2024 | 16.6M | −50% |
| FY2023 | 33.2M | +8% |
| FY2022 | 30.6M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 42M | +147% | |
| Q1 FY26 | 41.9M | +152% | |
| Q4 FY25 | 40.6M | +146% | |
| Q3 FY25 | 19.3M | +28% | |
| Q2 FY25 | 17M | +15% | |
| Q1 FY25 | 16.6M | +13% | |
| Q4 FY24 | 16.6M | −50% | |
| Q3 FY24 | 15.1M | +11% | |
| Q2 FY24 | 14.8M | +11% | |
| Q1 FY24 | 14.8M | −17% | |
| Q4 FY23 | 33.2M | +8% | |
| Q3 FY23 | 13.6M | +4% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Mira Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.